We also confirmed that the expression of proteins related with E2F pathway (CDK4, p-RB, E2F1, BCL2) were downregulated in MLL-r AML cell after A-485 treatment (Fig. 4E). The gene discussed is E2F1; the disease is acute myeloid leukemia.